# US 2024/0002837 A1 · Methods and systems for processing polynucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002837 A1
- Document ID: US20240002837A1
- Status: Published application
- Kind: A1
- Application number: 18/367,638
- Filed: 2023-09-13
- Published: 2024-01-04
- Earliest claimed: 2014-06-26
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Benjamin Hindson; Christopher Hindson; Michael Schnall-Levin; Kevin Ness; Mirna Jarosz; Serge Saxonov; Paul Hardenbol; Rajiv Bharadwaj; Xinying Zheng; Phillip Belgrader
- Web page: https://patentgrep.com/patent/US20240002837A1

## CPC

- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/683: involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C40B 20/04: Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
- C40B 50/16: involving encoding steps
- C12Q 2525/191: incorporating an adaptor
- C12Q 2535/122: Massive parallel sequencing
- C12Q 2537/143: Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
- C12Q 2537/149: Sequential reactions
- C12Q 2563/149: Particles, e.g. beads
- C12Q 2563/159: Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components
- C12Q 2563/179: the label being a nucleic acid
- C12Q 2565/629: being a microfluidic device
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

## Claims

### Claim at position 1

-27. (canceled)

### Claim 28

A method for analyzing cells comprising:
(a) contacting a cell with an antibody to provide the cell bound to the antibody, wherein the cell comprises a nucleic acid analyte, and wherein the antibody is attached to a reporter nucleic acid molecule comprising a reporter sequence;
(b) co-partitioning into a partition: (i) the cell bound to the antibody attached to the reporter nucleic acid molecule and (ii) a population of oligonucleotides, wherein oligonucleotides of the population of oligonucleotides comprise a partition-specific barcode sequence;
(c) generating a first nucleic acid construct from the reporter nucleic acid molecule and a first oligonucleotide of the population of oligonucleotides, the first nucleic acid construct comprising the reporter sequence or complement thereof, and the partition-specific barcode sequence or complement thereof; and
(d) generating a second nucleic acid construct from the nucleic acid analyte or complement thereof and a second oligonucleotide of the population of oligonucleotides, the second nucleic acid construct comprising a sequence from the nucleic acid analyte or complement thereof and the partition-specific barcode sequence or complement thereof.

### Claim 29 (depends on 28)

The method of claim 28, further comprising sequencing the first nucleic acid construct or derivative thereof to obtain sequencing reads, and using the sequencing reads to identify the reporter sequence and the partition-specific barcode sequence.

### Claim 30 (depends on 28)

The method of claim 28, further comprising sequencing the second nucleic acid construct or derivative thereof to obtain sequencing reads, and using the sequencing reads to identify the sequence from the nucleic acid analyte and the partition-specific barcode sequence.

### Claim 31 (depends on 28)

The method of claim 28, wherein (c) comprises hybridizing the reporter oligonucleotide to the first oligonucleotide of the population of oligonucleotides and performing a nucleic acid extension reaction to generate the first nucleic acid construct.

### Claim 32 (depends on 28)

The method of claim 28, wherein (d) comprises hybridizing the nucleic acid analyte or complement thereof to the second oligonucleotide of the population of oligonucleotides and performing a nucleic acid extension reaction to generate the second nucleic acid construct.

### Claim 33 (depends on 28)

The method of claim 28, wherein (c) and (d) are performed in the partition.

### Claim 34 (depends on 28)

The method of claim 28, wherein, in (b), the population of oligonucleotides is attached to a bead.

### Claim 35 (depends on 28)

The method of claim 28, wherein the first oligonucleotide of the population of oligonucleotides is complementary to at least a portion of the reporter oligonucleotide.

### Claim 36 (depends on 28)

The method of claim 28, wherein the second oligonucleotide of the population of oligonucleotides is complementary to at least a portion of the nucleic acid analyte or complement thereof.

### Claim 37 (depends on 28)

The method of claim 28, wherein the first oligonucleotide and the second oligonucleotide of the population of oligonucleotides comprise differing unique molecular sequences.

### Claim 38 (depends on 28)

The method of claim 28, wherein the first oligonucleotide comprises a first primer sequence and the second oligonucleotide comprises a second primer sequence.

### Claim 39 (depends on 28)

The method of claim 28, wherein the reporter oligonucleotide comprises a primer sequence.

### Claim 40 (depends on 28)

The method of claim 28, further comprising subjecting the first nucleic acid construct or derivative thereof and the second nucleic acid construct or derivative thereof to a nucleic acid amplification reaction.

### Claim 41 (depends on 28)

The method of claim 28, further comprising adding one or more first functional sequences to the first nucleic acid construct or derivative thereof and one or more second functional sequences to the second nucleic acid construct or derivative thereof, wherein the one or more first functional sequences and the one or more second functional sequences are configured to permit attachment to a flow cell of a sequencer.

### Claim 42 (depends on 28)

The method of claim 28, wherein the partition is a well or a droplet.

### Claim 43 (depends on 28)

The method of claim 28, wherein the partition is among a plurality of partitions comprising at least about 1,000 partitions.

### Claim 44 (depends on 28)

The method of claim 28, wherein the nucleic acid analyte comprises a messenger ribonucleic acid (mRNA) molecule.

### Claim 45

A method for analyzing cells comprising:
(a) providing a cell comprising a nucleic acid analyte, wherein the cell is bound to an antibody attached to a reporter oligonucleotide comprising a reporter sequence;
(b) providing a population of oligonucleotides, wherein oligonucleotides of the population of oligonucleotides share a common barcode sequence;
(c) co-partitioning: (i) the cell comprising the nucleic acid analyte and bound to the antibody attached to the reporter oligonucleotide and (ii) the population of oligonucleotides into a partition; and
(d) using the reporter oligonucleotide, the nucleic acid analyte, and the population of oligonucleotides to generate a sequencing library.

### Claim 46 (depends on 45)

The method of claim 45, wherein the reporter oligonucleotide comprises a poly-A sequence, wherein the population of oligonucleotides is attached to a bead, wherein the oligonucleotides of the population of oligonucleotides further comprise a poly-T sequence, and wherein (e) comprises (i) hybridizing the poly-A sequence of the reporter oligonucleotide to the poly-T sequence of an individual oligonucleotide of the oligonucleotides attached to the bead, to provide the bead comprising the reporter oligonucleotide attached thereto, and (ii) performing a nucleic acid extension reaction to generate a barcoded nucleic acid molecule.

### Claim 47 (depends on 45)

The method of claim 45, wherein the oligonucleotides of the population of oligonucleotides further comprise a poly-T sequence, wherein the nucleic acid analyte comprises a messenger ribonucleic acid RNA (mRNA) comprising a poly-A sequence, and wherein (e) comprises hybridizing the poly-A sequence of the mRNA to the poly-T sequence of an individual oligonucleotide of the oligonucleotides to provide the bead comprising the mRNA attached thereto; and (f) generating a nucleic acid construct comprising (i) a sequence corresponding to the mRNA and (ii) the partition-specific barcode sequence.

### Claim 48 (depends on 47)

The method of claim 47, further comprising sequencing the nucleic acid construct or a derivative thereof to identify the sequence corresponding to the mRNA and the barcode sequence.

### Claim 49 (depends on 45)

The method of claim 45, wherein the antibody is bound to a cell surface feature of the cell.

### Claim 50 (depends on 45)

The method of claim 45, wherein the antibody binds to a protein of the cell.

### Claim 51 (depends on 50)

The method of claim 50, wherein the protein comprises an intracellular protein.

### Claim 52 (depends on 50)

The method of claim 50, wherein the protein comprises a cell surface protein.

### Claim 53 (depends on 52)

The method of claim 52, wherein the cell surface protein is a cluster of differentiation (CD) protein.

### Claim 54 (depends on 45)

The method of claim 45, wherein the partition is a well.

### Claim 55

A method for cell analysis comprising:
(a) contacting a cell organelle with an antibody to provide the cell organelle bound to the antibody, wherein the cell organelle comprises a nucleic acid analyte, and wherein the antibody is attached to a reporter nucleic acid molecule comprising a reporter sequence;
(b) co-partitioning into a partition: (i) the cell organelle bound to the antibody attached to the reporter nucleic acid molecule and (ii) a population of oligonucleotides, wherein oligonucleotides of the population of oligonucleotides comprise a partition-specific barcode sequence;
(c) generating a first nucleic acid construct from the reporter nucleic acid molecule and a first oligonucleotide of the population of oligonucleotides, the first nucleic acid construct comprising (i) the reporter sequence or complement thereof, and (ii) the partition-specific barcode sequence or complement thereof; and
(d) generating a second nucleic acid construct from the nucleic acid analyte or complement thereof and a second oligonucleotide of the population of oligonucleotides, the second nucleic acid construct comprising a sequence of the nucleic acid analyte or complement thereof and the partition-specific barcode sequence or complement thereof.

### Claim 56 (depends on 55)

The method of claim 55, wherein the nucleic acid analyte is a messenger ribonucleic acid RNA (mRNA).

### Claim 57 (depends on 55)

The method of claim 55, wherein the antibody binds to a protein of the cell organelle.
